Quantitative In Vivo Assessment of Tumour Vasculature-targeted Liposomes
Targeting angiogenic vasculature has been validated as a viable approach for cancer imaging and therapy. The tumour vasculature-specific ligand asparagine-glycine-arginine (NGR) peptide targets the isoform of aminopeptidase N (CD13) expressed on endothelial cells lining angiogenic vessels. CD13 has...
Main Author: | |
---|---|
Other Authors: | |
Language: | en_ca |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/30116 |